Which individual performs the primary role of a biomedical scientist? A.
Max studies potential advances and breakthroughs in health science.
B.
Lois creates a safe and comfortable environment for patients and healthcare providers.
C.
Peter manufactures a new form of insulin.
D.
Raymond develops systems that ensure the privacy of patients’ health data.

List the therapeutic actions, indications, pharmacokinetics, contraindications, most common adverse reactions, and important drug–drug interactions for each of these medications

Anurse is teaching about a new prescription for infliximab to a client who has rheumatoid arthritis. which of the following information should the nurse include in the teaching? a. “you will receive a mantoux test before the initial medication dose.” b. “you might experience diarrhea during the first 2 weeks of treatment.” c. “you will receive the medication every week for 6 weeks.” d. “you should receive the intranasal influenza vaccine.”

Cj is a 53 year old african american female presenting to pharmacy for first-time certification and cmr so that she may start getting her medications at no cost. cj states that her main concern about her health is her diabetes. pmh: t2dm, htn, hyperlipidemia sh: denies tobacco and illicit drug use, occasional alcohol use (1-2 drinks/month) fh: unknown allergies: penicillin (unknown reaction; had reaction when young). medications: lisinopril 5 mg daily aspirin 81 mg daily simvastatin 20 mg daily wt 231 lbs (105 kg), ht 5’6”, bmi 37.3 (obese), ibw 59.3 kg, bp 145/80, hr 98, random blood glucose 395, a1c 11.2%, estimated 10-year ascvd risk 9.5% drug-related problems: 1. uncontrolled t2dm 2. uncontrolled htn 3. suboptimal statin intensity 1) identify two pieces of objective data included in this case: 2) what kind of monitoring needs performed for the new prescription for this patient? 3) based on your case how would you counsel the patient on the new prescription medication? provide examples of specific aspects you would include in your patient education. 4) review your patient case. identify any medications that do not have a corresponding disease state. 5) review your patient case. identify any disease states are not treated by current medications. 6) what otc (over the counter) product would you recommend for this patient (based on the patient request for an otc product? include dose, frequency of administration, route of administration, and critical counseling points.